다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
USOTC
Ligand Pharmaceuticals Incorporated (PK) (LGNZZ)
Ligand Pharmaceuticals Incorporated (PK) (LGNZZ) 뉴스

LGNZZ

Ligand Pharmaceuticals (PK) (LGNZZ)

Ligand Pharmaceuticals Incorporated (PK)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:LGNZZ

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	07:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/14	06:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/10	07:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/10	07:03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/09	05:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/08	05:03	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/07	20:36	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/06/06	05:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/05/09	05:29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/05/07	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	08:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	08:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	08:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	05:10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	05:07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/08	05:41	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/07	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/03	05:19	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/03/14	07:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/28	07:38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/19	07:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/19	07:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/19	07:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/19	07:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/15	03:19	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/15	01:34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/15	00:04	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/14	21:45	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/14	01:09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/12	22:10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)

검색 관련기사 보기:USOTC:LGNZZ

1 2 3 4 5 6 7 8 9 다음 >>

Anz Bank 1.438%

Silkeborg If Invest A/s

Total Capital Internatio...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관